Results 101 to 110 of about 745,977 (137)

Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis. [PDF]

J Neuroinflammation
Álvarez-Sánchez E, Carbayo Á, Valle-Tamayo N, Muñoz L, Aumatell J, Torres S, Rubio-Guerra S, García-Castro J, Selma-González J, Alcolea D, Turon-Sans J, Lleó A, Illán-Gala I, Fortea J, Rojas-García R, Dols-Icardo O.   +15 more
europepmc   +1 more source

La esclerosis lateral amiotrófica (ELA)

Acta Neurológica Colombiana, 2007
JAVIER TORRES ZAFRA, GERMAN ENRIQUE PEREZ R.   +1 more
doaj   +2 more sources

Nuclear pore complex dysfunction drives TDP-43 pathology in ALS. [PDF]

Redox Biol
Ramírez-Núñez O, Rico-Ríos S, Torres P, Ayala V, Fernàndez-Bernal A, Ceron-Codorniu M, Andrés-Benito P, Vinyals A, Maqsood S, Ferrer I, Pamplona R, Portero-Otin M.   +11 more
europepmc   +1 more source

[XXVIII Reunión Anual de la Sociedad Canaria de Neurología (SOCANE). Libro de Comunicaciones]. [PDF]

Rev Neurol
europepmc   +1 more source

Frequency of orthostatic hypotension in the Pooled Resource Open-Access ALS Clinical Trials database. [PDF]

Front Neurol
Quarracino C, Capani F, Otero-Losada M, Rodríguez GE, Pérez-Lloret S.   +4 more
europepmc   +1 more source

Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration. [PDF]

J Prev Alzheimers Dis
García-Castro J, VandeVrede L, Donohue MC, Vaqué-Alcázar L, Rubio-Guerra S, Selma-González J, Heuer HW, Morcillo-Nieto AO, Franquesa M, Dols-Icardo O, Bejanin A, Belbin O, Fortea J, Alcolea D, Carmona-Iragui M, Abdelnour C, Barroeta I, Santos-Santos M, Sánchez Saudinós MB, Sala I, Lleó A, Gorno-Tempini ML, Mandelli ML, Raman R, Wills AA, Barragan E, Litvan I, Boeve B, Dickerson B, Grossman M, Huey ED, Irwin DJ, Pantelyat A, Tartaglia C, Rojas JC, Boxer AL, Illán-Gala I, Four Repeat Tau Neuroimaging Initiative (4RTNI) and the AL108-231 Investigators.   +37 more
europepmc   +1 more source

Incidence of advanced chronic disease, need for palliative care and in-hospital mortality [PDF]

Rev Med Inst Mex Seguro Soc
Canizal-Oñate JL, Tovar-Rodríguez D, León-Armas N, Martínez-Díaz G, López-Zamora B, Cruz-Domínguez MDP, Arrucha-Cozaya M, Vera-Lastra OL, Medina-García G.   +8 more
europepmc   +1 more source

[Use of disease-modifying therapies in spinal muscular atrophy 5q in Mexico]. [PDF]

Rev Med Inst Mex Seguro Soc
Meza-Cano ME, Molina-Castillo C.
europepmc   +1 more source